Ignite Creation Date:
2024-10-25 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06605365
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-18
Brief Title:
Cross-linked CMC and Silk Proteins in Eye Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Ophthalmic Solution in Drye Eye Patients
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Data analyses and revision of the DED symptoms A novel ophthalmic solution containing cross-linked CMC CX-CMC and Silk Proteins SP has been made available on the market
Both molecules have been widely studied for their viscoelastic and hydrating and wound healing properties
This new ophthalmic solution is the first on the market formulated with a CX-CMC and SP
Both molecules have been widely studied for their viscoelastic and hydrating and wound healing properties
This new ophthalmic solution is the first on the market formulated with a CX-CMC and SP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None